Skip to content
lifestyle.newsblaze.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alvotech
FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
October 5, 2026
Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations
August 31, 2026
Alvotech to present at upcoming investor conferences in September
August 27, 2026
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
August 21, 2026
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
August 19, 2026
Alvotech to Report Financial Results for H1 2026
August 10, 2026
Alvotech announces successful closure of FDA inspection of manufacturing facility
July 29, 2026
Alvotech further strengthens liquidity by securing term loan facility of $75 million
July 1, 2026
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
May 11, 2026
Alvotech Q1 2026 Financial Results
May 6, 2026
1
2
Next Page
→